Centessa Pharmaceuticals Plc ADR (CNTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -235,757 | -151,085 | -216,207 | -381,900 | -10,663 |
| Depreciation Amortization | 942 | 810 | 131 | 34 | N/A |
| Income taxes - deferred | 2,653 | -26,529 | -2,857 | N/A | N/A |
| Accounts payable and accrued liabilities | -4,585 | -2,722 | 6,351 | 3,799 | -49 |
| Other Working Capital | 22,164 | -18,830 | -2,658 | -5,379 | -489 |
| Other Operating Activity | 72,528 | 38,014 | 14,694 | 247,288 | 571 |
| Operating Cash Flow | $-142,055 | $-160,342 | $-200,546 | $-136,158 | $-10,630 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 31,301 | -126,835 | N/A | N/A | N/A |
| PPE Investments | -34 | -169 | -1,137 | -186 | N/A |
| Net Acquisitions | N/A | N/A | N/A | 63,442 | N/A |
| Other Investing Activity | 0 | 0 | 206 | 0 | 0 |
| Investing Cash Flow | $31,267 | $-127,004 | $-931 | $63,256 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 109,335 | N/A | N/A | 73,930 | N/A |
| Common Stock Issued | 370,832 | 21,117 | 718 | 344,915 | N/A |
| Other Financing Activity | -115,415 | 0 | -261 | 241,302 | 1,362 |
| Financing Cash Flow | $364,752 | $21,117 | $457 | $660,147 | $1,362 |
| Exchange Rate Effect | 1,227 | 615 | -418 | 1,902 | -75 |
| Beginning Cash Position | 128,030 | 393,644 | 595,082 | 12,193 | 16,570 |
| End Cash Position | 383,221 | 128,030 | 393,644 | 601,340 | 7,227 |
| Net Cash Flow | $255,191 | $-265,614 | $-201,438 | $589,147 | $-9,343 |
| Free Cash Flow | |||||
| Operating Cash Flow | -142,055 | -160,342 | -200,546 | -136,158 | -10,630 |
| Capital Expenditure | -34 | -169 | -1,137 | -186 | N/A |
| Free Cash Flow | -142,089 | -160,511 | -201,683 | -136,344 | -10,630 |